• About
  • Subscribe
  • Advertise
  • Contact
Sunday, July 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Myopia control – confused or in control?

by Staff Writer
April 2, 2017
in Devices
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

I was encouraged that practitioner concern about the increasing frequency of childhood myopia was high in Australasia – median 7/10. Practitioners in Europe and North and South America reported similar rates of concern. Those in Asia were the most worring – 9/10.There is a reason for concern. In 2010, 1.9 billion people worldwide were myopic and 205 million had high myopia. Assuming current rates of increase, the Brien Holden Vision Institute estimates that:

  • Worldwide, presently there are about 2–2.5 billion people with myopia
  • By 2050, 5 billion people will be myopic, which will be half the world’s population
  • In addition, by 2050 there will be almost 1 billion high myopes, 10% of the world’s population

{{quote-A:R-W:450-Q: Neither of these strategies has been shown to slow progression. Even more concerning however is that, although it has been shown that undercorrection makes myopia progress faster, there are still some practitioners using this strategy. }}Also, we know that myopia increases the risk of blindness due to myopic maculopathy, retinal detachment, glaucoma and cataracts. High myopia (5.00 D or more) significantly increases the risk of these sigh–threatening conditions and is a major cause of blindness or vision impairment.It is encouraging that a 50% reduction in the rate of progression would result in more than 90% fewer high myopes. This would substantially reduce the risks of sight–threatening complications of myopia later in life.How do you know who is at greatest risk?There are two very strong predictors:

  • Refraction less than +0.75 D at age 6
  • Both parents being myopic

It is recommended that if you see a young child who is less than +1.00 D do a cycloplegic refraction. Then review th every 6 months for at least 12-18 months to see if there is any change.The reason why the article confused me is because it reported that the majority of practitioners prescribed either single vision (full correction) spectacles or single vision contact lenses for progressing or young myopes. Neither of these strategies has been shown to slow progression. Even more concerning however is that, although it has been shown that undercorrection makes myopia progress faster, there are still some practitioners using this strategy.I don’t understand? Controlling myopia progression is essential for long–term eye health.Regarding risk factors, Paul Gifford presented a fabulous lecture at OSO 2016 about a great resource created together with Kate Gifford to help practitioners – myopiaprofile.com. It contains the latest research on myopia development and assists in treatment strategies. They have also created a resource for parents – mykidsvision.org. This simple online survey helps parents assess their child’s risk of myopia.Fortunately, we do have optical and pharmacological treatment strategies – as well as lifestyle interventions – to help delay onset and control progression. Of all the methods available to slow the progress of myopia, orthoK, soft bifocal contact lenses, and atropine, are the most effective.Furthermore, patients should be encouraged to spend at least two hours per day outdoors.The most common reasons given for not providing myopia control were:

  • Uneconomical
  • Inadequate information
  • Outcomes unpredictable or ineffective
  • Concerns about safety

I found this very confusing because none of these are true!If you have similar concerns, the OSO will run four boot–camps this year about orthoK and myopia control.US researcher Dr John F. Dartini once said, “Deep inside every human being there is a yearning to do something extraordinary and to be of great, vast service to humanity.”I believe it is of great service to humanity to help prevent avoidable blindness with orthoK and other forms of myopia control.To me it is an extraordinary privilege to tell a parent – “I’m not just going to watch your child getting worse. I am going to do everything I can to slow his or her myopia so they are more likely to have a lifetime of great vision.” 


Name: Amanda RungisQualifications: MOptom, BOptom HonsBusiness: Sure Eye CarePosition: OwnerLocation: West Gosford, NSWYears in the profession: 31 years in the industry – 23 as an optometrist

 

Related Posts

The CLARUS 700 ICGA feature extends imaging deeper into the choroidal circulation. Image: ZEISS.

Expanding retinal imaging across clinical settings with ZEISS

by Adam Spencer
May 19, 2026

New ultra-widefield imaging technology is supporting ophthalmologists and optometrists with enhanced visualisation, streamlined workflows, and improved patient understanding across a...

Optos will demonstrate how optomap technology can enhance clinical decision-making, improve patient flow, and increase practice efficiency. Image: Optos.

Optos to showcase ultra-widefield imaging technology at key events in 2026

by Staff Writer
April 23, 2026

Optos is continuing to support eyecare professionals across Australia and New Zealand in 2026, bringing its industry-leading innovation to key...

The slit lamp is a device during eye screening. Image: Svitlana/stock.adobe.com.

Scientists develop low-cost, portable slit lamp to increase access to screening

by Staff Writer
March 31, 2026

Scientists in Japan believe they have helped to improve access to eye screening by developing a portable, low-cost slit lamp....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited